Asia Pacific In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Donor, Frozen Donor), By Providers, By Country, And Segment Forecasts, 2024 - 2030

Market Size & Trends

The Asia Pacific in vitro fertilization market size was estimated at USD 8.7 billion in 2023 and it is expected to grow at a CAGR of 7.3% from 2024 to 2030. Some of the key growth drivers for this market are growing new cases of infertility, increasing availability of in vitro fertilization (IVF) technology treatment, advancements in technology, an increase in the average age of men and women entering marriage, favorable funding offered by governments in the region, and strategic initiatives such as mergers & acquisitions undertaken by key companies in the industry.

Asia Pacific in vitro fertilization market held a 34.5% share of the global market in 2023. Growing new cases of infertility in both men and women are the major issues faced by the population in Asia Pacific. Drastic changes in lifestyle, ever-increasing hours of work, desk-bound nature of work routines, consumption of harmful elements and chemicals through food products, growing occurrence of health issues such as pelvic inflammatory disease, polycystic ovary syndrome, ovarian failure, over/underactive thyroid glands, side effects caused by consumption of drugs and medicines are some of the key root causes leading to infertility.

In recent years, technology has evolved at a rapid pace and the industry has witnessed crucial advancements in technology associated with IVF. Governments in the region have been introducing supportive and encouraging funding for the in vitro fertilization industry for the last few years. Furthermore, the advent of techniques such as Physiological Intra-cytoplasmic Sperm Injection (PICSI), and tactical initiatives such as partnerships, collaborations, mergers & acquisitions (M&A), and expansions implemented by prominent establishments in the industry have been fueling growth for this market in Asia Pacific region.

To enhance the success rate of IVF, companies and governments have been investing resources in research and development associated with assistive technology. Some of the technologies launched through such R&D efforts include Percutaneous Epidydimal Sperm Aspiration & Testicular Sperm Extraction (PESA & TESE), assisted hatching, three-parent IVF, genetic diagnosis, vitrification, mini-IVF, and egg/sperm freezing. 

Instrument Insights

Based on instrument, the culture media segment dominated the market in 2023. Factors driving growth for this segment include a rise in research efforts to improve the culture media and accessibility to necessary funding. The culture media segment entails embryo culture media, cryopreservation media, sperm processing media, and ovum processing media.

The disposable devices segment is anticipated to experience the fastest growth rate during the forecast period. This segment is primarily fueled by aspects such as constant new launches of disposable devices, such as slides, chambers, and needles to adhere to regulatory compliances. Such portfolio developments are expected to generate an increased reception of disposable IVF devices.

Procedure Insights

Based on procedure, the frozen non-donor segment dominated the market with the largest revenue share in 2023. One of the primary dynamics causing this growth is the cost-effectiveness associated with this procedure. The number of IVF cycles with the aid of frozen non-donor procedures is increasing as compared to other procedures. This technique does not require fertility drug stimulation as well. In addition, the less invasive nature has been acting as a key driver behind the growing demand for this procedure.

The fresh donor segment is anticipated to witness a significant CAGR of 7.3% from 2024 to 2030. Fresh oocytes are fertilized by the fresh donor eggs. A large number of couples are inclined towards the adoption of this procedure as it is expected to provide a better success rate as compared to the frozen eggs procedure.

Providers Insights

Based on providers, fertility clinics dominated the market with the largest revenue share in 2023. One of the main aspects fueling growth for this segment is an upsurge in demand for assisted reproductive technology (ART). Furthermore, factors such as the assistance offered by professionals, less or no likelihood of contact with Hospital-Acquired Infections (HAIs), and cost-effectiveness are producing growth for this segment.

Hospitals and other settings segment is likely to experience a CAGR of 7.0% from 2024 to 2030. Asia Pacific region has been going through a vital transition in terms of development and enhancement in healthcare infrastructure. Several specialty hospitals in countries such as India have been providing diligent treatments for infertility, including In-vitro Fertilization (IVF).

Country Insights

Japan In Vitro Fertilization Market Trends

Japan in vitro fertilization market dominated the regional industry and held a revenue share of 34.7% in 2023. This can be attributed to the presence of a defined regulatory framework and the introduction of newer techniques, such as AUGMENT, delayed marriages, lifestyle changes, and a decrease in the birth rate. In addition, the government of Japan has recognized the significance of fertility treatments and it has implemented crucial policies & regulations to support IVF.

India In Vitro Fertilization Market Trends

The in vitro fertilization market in India is likely to experience a CAGR of 8.0% from 2024 to 2030. Factors attributing to this growth are delayed marriages, a rise in the average age of pregnancy, an increase in infertility rates, higher disposable income levels, and awareness about the availability of infertility treatments. With a success rate ranging from 60% to 70%, IVF treatments played a significant role in this growth, attracting a growing number of individuals and couples seeking fertility solutions.

Key Asia Pacific In Vitro Fertilization Company Insights

Some of the prominent organizations in the Asia Pacific in vitro fertilization market include Southend Fertility Clinic, Kitazato Corporation, Amrita Hospital, Morpheus IVF (MLSPL), Babies & Us Fertility IVF & ICSI Center and others. In recent years, to deliver a greater success rate of IVF treatments, organizations operating in the industry have been adopting the latest technologies and advanced treatments.

• Babies & Us Fertility IVF & ICSI Center is one of the leading brands in the IVF industry of India. The organization offers a range of fertility services right from diagnosis to planning a conception. Fertility treatments provided by the organization include IVF, sequential transfer, Intracytoplasmic morphologically selected sperm injection (IMSI), Intracytoplasmic sperm injection (ICSI), assisted laser hatching, and more.

• Amrita Hospital, one of the largest multi-specialist hospitals in India, operates in two prime locations including Kochi and Faridabad with a capacity of more than 1,300 beds. The facility at Vytila, The Department of Reproductive Medicine - Amrita Fertility Centre, offers comprehensive fertility treatments backed by innovation and an evidence-based approach. The services provided here are Advanced hystero-laparoscopic surgery, Saline sonosalpingography (SSG), Fertility & sexual counselling, Detailed sperm assessment, and Preconception and genetic counselling. In addition, they also assist couples and patients with Intracytoplasmic sperm injection (ICSI), Semen cryopreservation, Treatment for sexual dysfunction, Frozen embryo transfer (FET), Embryo & Oocytes cryopreservation, and more.

Recent Developments

• In May 2024, Birla Fertility & IVF, one of the major brands in the India-based IVF industry and wing of the renowned C K Birla Group, acquired ARMC IVF Fertility Centre ensuring its entry into the Southern part of the country. With this acquisition, now Birla Fertility & IVF operates 37 centers across India.

Asia Pacific In Vitro Fertilization Market Report Segmentation

Asia Pacific In Vitro Fertilization Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Asia Pacific in vitro fertilization market report based on procedure, providers, instruments, and country:

• Instrument Outlook (Revenue, USD Million, 2018 - 2030)

  • Disposable Devices

  • Culture Media

    • Cryopreservation Media

    • Embryo Culture Media

    • Ovum Processing Media

    • Sperm Processing Media

  • Equipment

    • Sperm Analyzer Systems

    • Imaging Systems

    • Ovum Aspiration Pumps

    • Micromanipulator Systems

    • Incubators

    • Gas Analyzers

    • Laser Systems

    • Cryosystems

    • Sperm Separation Devices

    • IVF Cabinets

    • Anti-vibration Tables

    • Witness Systems

    • Others

• Procedure Outlook (Revenue, USD Million, 2018 - 2030)

  • Fresh Donor

  • Frozen Donor

  • Fresh Non-donor

  • Frozen Non-donor

• Providers Outlook (Revenue, USD Million, 2018 - 2030)

  • Fertility Clinics

  • Hospitals & Other Settings

• Country Outlook (Revenue, USD Million, 2018 - 2030)

  • Japan

  • China

  • India

  • South Korea

  • Australia